Literature DB >> 3570037

Raised plasma concentrations of platelet factor 4 (PF4) in Crohn's disease.

M Simi, S Leardi, M T Tebano, M Castelli, F M Costantini, V Speranza.   

Abstract

Plasma platelet factor 4 (PF4), secreted by the platelets, is an index of platelet aggregation and thromboembolic risk. The authors assessed PF4 in 20 patients with Crohn's disease (ileitis in 13 patients, ileocolitis in seven) and in 20 healthy volunteers. Disease activity was low (Crohn's Disease Activity Index less than 150) in 11 patients and high in nine. Radioimmunoassay of PF4 using Abbott's Kit was performed on one sample of plasma from each subject (nv less than or equal to 0.324 nmol/ml), (nv less than or equal to 10 ng/ml). A significantly higher concentration of PF4 was found in Crohn's disease patients: 4.625 +/- 1.1 nmol/ml (142.5 +/- 36 ng/ml) than in the control group: 0.189 +/- 0.07 nmol/ml (5.6 +/- 4.8 ng/ml) (Z = 5.396, p less than 0.0001). No correlation was present between PF4 levels and activity, the site of disease, or medical treatment with or without prednisone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570037      PMCID: PMC1432701          DOI: 10.1136/gut.28.3.336

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

2.  Coagulation studies in ulcerative colitis and Crohn's disease.

Authors:  A Lam; I T Borda; M J Inwood; S Thomson
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

3.  A radioimmunoassay for platelet factor 4.

Authors:  A E Bolton; C A Ludlam; D S Pepper; S Moore; J D Cash
Journal:  Thromb Res       Date:  1976-01       Impact factor: 3.944

4.  Platelet survival in patients with prosthetic heart valves.

Authors:  R K Stuart; J W McDonald; S P Ahuja; J C Coles
Journal:  Am J Cardiol       Date:  1974-06       Impact factor: 2.778

5.  Letter: Heparin thrombin clotting-time and platelet factor 4.

Authors:  J R O'Brien; M Etherington; S Jamieson; P Lawford
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

6.  Thrombocytosis in ulcerative colitis and Crohn's disease.

Authors:  I Talstad; K Rootwelt; E Gjone
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

7.  Assay of platelet factor 4 in plasma.

Authors:  V Fuster; F J Kazmier; J D Cash; E J Bowie; C A Owen
Journal:  Mayo Clin Proc       Date:  1973-02       Impact factor: 7.616

8.  Isolation and some properties of the heparin-neutralizing factor (PF4) released from human blood platelets.

Authors:  R Käser-Glanzmann; M Jakábová; E F Lüscher
Journal:  Experientia       Date:  1972-10-15

9.  Histopathology of Crohn's disease.

Authors:  B S Morson
Journal:  Proc R Soc Med       Date:  1968-01

10.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

View more
  11 in total

Review 1.  Mesenteric arterial thrombosis as a complication of Crohn's disease.

Authors:  P Sanghavi; A Paramesh; A Dwivedi; T Markova; T Phan
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

3.  Circulating cell-derived microparticles in Crohn's disease.

Authors:  Patrick Chamouard; Dominique Desprez; Bénédicte Hugel; Corinne Kunzelmann; Carole Gidon-Jeangirard; Michel Lessard; René Baumann; Jean-Marie Freyssinet; Lélia Grunebaum
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

Review 4.  Platelet dysfunction: a new dimension in inflammatory bowel disease.

Authors:  C E Collins; D S Rampton
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

5.  Prevalence and significance of anticardiolipin antibodies in Crohn's disease.

Authors:  P Chamouard; L Grunebaum; M L Wiesel; J M Freyssinet; B Duclos; J P Cazenave; R Baumann
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

6.  Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.

Authors:  Hiroshi Takeyama; Tsunekazu Mizushima; Hideki Iijima; Shinzaki Shinichiro; Mamoru Uemura; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2015-06-16       Impact factor: 3.199

7.  Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides.

Authors:  Amosy E M'Koma; Erin H Seeley; Mary K Washington; David A Schwartz; Roberta L Muldoon; Alan J Herline; Paul E Wise; Richard M Caprioli
Journal:  Inflamm Bowel Dis       Date:  2010-08-30       Impact factor: 5.325

8.  Thromboembolism in inflammatory bowel disease: role of platelets.

Authors:  M J Webberley; M T Hart; V Melikian
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

9.  Touch of chemokines.

Authors:  Xavier Blanchet; Marcella Langer; Christian Weber; Rory R Koenen; Philipp von Hundelshausen
Journal:  Front Immunol       Date:  2012-07-12       Impact factor: 7.561

10.  Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study.

Authors:  Lei Ye; Yu-Ping Zhang; Na Yu; Ya-Xu Jia; Shu-Jun Wan; Fang-Yu Wang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.